IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients

Clinical trial NCT05104762 · COMPLETED

Trial details

NCT number: NCT05104762
Sponsor: Assiut University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Guillain-Barre Syndrome

Start date: 2021-09-01
Primary completion: 2022-03-02
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.